Information Collection Request

[NCCDPHP] List of Ingredients Added to Tobacco in the Manufacture of Cigarette Products

ICR 202604-0920-005 · OMB 0920-0210 · Received in OIRA

Forms and Documents
DocumentTypeStatusAvailability
Recommended Cigarette Ingredient Reporting Format - FCLAA Form and Instruction Modified Available
0210 PN.pdf Supplementary Document Uploaded 2026-05-05 Available
0920 0210 Att 7 Human Subjects Non-research Determ.pdf Supplementary Document Uploaded 2026-05-05 Available
0920 0210 Att 6b Civil Penalties for Disclosure of Confidential Info (18 U.S.C. 1905).pdf Supplementary Document Uploaded 2026-05-05 Available
0920 0210 Att 6a Privileged Information Guidelines.pdf Supplementary Document Uploaded 2026-05-05 Available
0920 0210 Att 5 Initial FRN (1985).pdf Supplementary Document Uploaded 2026-05-05 Available
Att 4 60 Day FRN.pdf Supplementary Document Uploaded 2026-05-05 Available
0920 0210 Att 3b Recommencement of Reporting Require.pdf Supplementary Document Uploaded 2026-05-05 Available
0920 0210 Att 3a Change in Reporting Require.pdf Supplementary Document Uploaded 2026-05-05 Available
0210 Att 2 Compliance Cert Manufacs Pkgers & Importers of Tobacco Products.pdf Supplementary Document Uploaded 2026-05-05 Available
0210 Att 1b Fed Cig Labeling and Ad Act (15 U.S.C. 1331-1341).pdf Supplementary Document Uploaded 2026-05-05 Available
0210 Att 1a Comp Smoking Education Act of 1984 (15 U.S.C. 1335a).pdf Supplementary Document Uploaded 2026-05-05 Available
0920 0210 SSA_final.docx Supporting Statement A Uploaded 2026-05-05 Available
IC Document Collections
IC IDCollectionTypeStatusForm
183310 Ingredient Report Form and Instruction ModifiedRecommended Cigarette Ingredient Reporting Format - FCLAA
ICR Details
0920-0210 202604-0920-005
Received in OIRA 202203-0920-015
HHS/CDC 0920-26-0188
[NCCDPHP] List of Ingredients Added to Tobacco in the Manufacture of Cigarette Products
Reinstatement with change of a previously approved collection   No
Regular 05/07/2026
  Requested Previously Approved
36 Months From Approved
55 0
358 0
0 0

This is a legislatively mandated information collection. As required by the Federal Cigarette Labeling and Advertising Act (15 U.S.C. 1335a(a), or P.L .89-92), CDC's Office on Smoking and Health collects information from cigarette manufacturers, packagers and importers about the ingredients used in cigarette products. This collection is commonly known as the Ingredient Report. This is a reinstatement with very minor changes.

PL: Pub.L. 98 - 474 1341 Name of Law: Comprehensive Smoking Education Act
   US Code: 15 USC 1331 Name of Law: Federal Cigarette Labeling and Advertising Act
  
None

Not associated with rulemaking

  90 FR 43448 09/09/2025
91 FR 24241 05/05/2026
No

1
IC Title Form No. Form Name
Ingredient Report n/a Recommended Cigarette Ingredient Reporting Format - FCLAA

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 55 0 0 55 0 0
Annual Time Burden (Hours) 358 0 0 358 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
This is a Reinstatement.

$12,490
No
    No
    No
No
No
No
No
Kevin Joyce 404 639-1944 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
05/07/2026